Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D002369:Castration; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000378:metabolism; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D009929:Organ Size / Q000187:drug effects; D011397:Promegestone / Q000378:metabolism; D051381:Rats; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D013629:Tamoxifen; C016601:afimoxifene; D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D011397:Promegestone